SCRI-Nashville/Tennessee Oncology

Nashville, Tennessee 37203

0 studies enrolling now · 1 studies all time

What they study most

Solid Tumor, Adult

Studies at this site

• Phase 1 Study of RBN-2397, an Oral PARP7 Inhibitor, in Patients With Solid Tumors — Status unconfirmed